County of Morris v. Purdue Pharma L.P. et al

Consolidated
Lead case: 1:17-md-02804

Ohio Northern District Court
Judge:	Dan Aaron Polster
Case #:	1:17-op-45086
Nature of Suit	367 Torts - Personal Injury - Health Care/Pharmaceutical Personal Injury/Product Liability
Cause	28:1332 Diversity-Product Liability

Case Filed:	Dec 15, 2017
Case in other court:	Texas Eastern, 2:17-cv-00725

Docket
Parties (31)

Last checked: Friday Nov 08, 2019 4:59 PM EST

Defendant Janssen Pharmaceutica Inc.	Represented By Stephen E. McConnico Scott, Douglass & Mcconnico contact info
Defendant Watson Laboratories Inc.	Represented By Craig Andrew Stanfield Invalid Address - Morgan Lewis & Bockius, Llp - Houston contact info
Defendant The Purdue Frederick Company	Represented By Noelle M. Reed Skadden Arps Slate Meagher & Flom - Houston contact info
Defendant SpecGx LLC
Defendant Smith Drug Company
Defendant Purdue Pharma L.P.	Represented By Noelle M. Reed Skadden Arps Slate Meagher & Flom - Houston contact info
Defendant Purdue Pharma Inc.	Represented By Noelle M. Reed Skadden Arps Slate Meagher & Flom - Houston contact info
Defendant Par Pharmaceutical, Inc.
Defendant Par Pharmaceutical Companies, Inc.
Defendant Ortho-Mcneil-Janssen Pharmaceuticals Inc.	Represented By Stephen E. McConnico Scott, Douglass & Mcconnico contact info
Defendant McKesson Corporation	Represented By Mark H. Lynch Covington & Burling - Washington contact info Robert Philip Scott Blank Rome - Houston contact info
Defendant Johnson & Johnson	Represented By Stephen E. McConnico Scott, Douglass & Mcconnico contact info
Defendant Janssen Pharmaceuticals Inc.	Represented By Stephen E. McConnico Scott, Douglass & Mcconnico contact info
Defendant Endo Pharmaceuticals Inc.	Represented By Hannah DeMarco Sibiski Arnold & Porter Kaye Scholer LLP contact info
Defendant Endo Health Solutions Inc.	Represented By Hannah DeMarco Sibiski Arnold & Porter Kaye Scholer LLP contact info
Defendant Does 1-100, Inclusive
Defendant Cardinal Health Inc.	Represented By Christopher Scott Geyer Williams & Connolly contact info
Defendant Amneal Pharmaceuticals LLC
Defendant AmerisourceBergen Drug Corporation
Defendant AmerisourceBergen Corporation	Represented By Melissa Richards Smith Gillam & Smith contact info
Defendant Allergan PLC
Defendant Allergan Finance LLC	Represented By Jack Wesley Hill Ward & Smith contact info
Defendant Actavis Pharma, Inc.	Represented By Craig Andrew Stanfield Invalid Address - Morgan Lewis & Bockius, Llp - Houston contact info
Defendant Actavis LLC	Represented By Craig Andrew Stanfield Invalid Address - Morgan Lewis & Bockius, Llp - Houston contact info
Plaintiff County of Morris	Represented By JoDee Neil Simon Greenstone Panatier contact info Jeffrey B. Simon Simon Greenstone Panatier contact info John F. Walker Martin Walker contact info Reid W. Martin Martin Walker contact info Amy M. Carter Simon Greenstone Panatier contact info
TERMINATED PARTIES
Defendant Teva Pharmaceuticals USA, Inc. Terminated: 04/11/2018	Represented By Craig Andrew Stanfield Invalid Address - Morgan Lewis & Bockius, Llp - Houston contact info
Defendant Teva Pharmaceutical Industries Ltd. Terminated: 04/11/2018
Defendant Knoll Pharmaceutical Company Terminated: 03/23/2018	Represented By J. Laurens Wilkes Jones Day - Houston contact info
Defendant Insys Therapeutics, Inc. Terminated: 03/24/2018	Represented By Nicholas Alex Sarokhanian Holland & Knight - Dallas contact info
Defendant Cephalon Inc. Terminated: 04/11/2018	Represented By Craig Andrew Stanfield Invalid Address - Morgan Lewis & Bockius, Llp - Houston contact info
Defendant Abbott Laboratories, Inc. Terminated: 03/01/2018	Represented By Alper T. Ertas Venable - San Francisco contact info James K. O'Connor Venable - Baltimore contact info John A. McCauley Venable - Baltimore contact info

Docket last updated: 04/08/2019 4:28 PM EDT

Friday, November 03, 2017
		Case assigned to District Judge Rodney Gilstrap. (ch, ) [Transferred from txed on 12/15/2017.] Related: [-]
		In accordance with the provisions of 28 USC Section 636(c), you are hereby notified that a U.S. Magistrate Judge of this district court is available to conduct any or all proceedings in this case including a jury or non-jury trial and to order the entry of a final judgment. The form[LINK:Consent to Proceed Before Magistrate Judge] is available on our website. All signed consent forms, excluding pro se parties, should be filed electronically using the event Notice Regarding Consent to Proceed Before Magistrate Judge . (ch, ) [Transferred from txed on 12/15/2017.] Related: [-]
1		1 59 pgs COMPLAINT AND JURY DEMAND against All Defendants ( Filing fee $ 400 receipt number 0540-6538572.), filed by County of Morris.(Simon, Jeffrey) [Transferred from txed on 12/15/2017.] Related: [-]
		Att: 1 Civil Cover Sheet
2		2 SUMMONS Issued as to Abbott Laboratories Inc, Actavis LLC, Actavis Pharma, Inc., Allergan Finance LLC, AmerisourceBergen Corporation, Cardinal Health, Inc., Cephalon Inc., Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Insys Therapeutics, Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Knoll Pharmaceutical Company, McKesson Corporation, Purdue Pharma Inc, Purdue Pharma L.P., Teva Pharmaceuticals USA, Inc., The Purdue Frederick Company, Watson Laboratories, Inc..(ch, ) [Transferred from txed on 12/15/2017.] Related: [-]
		Att: 1 Summons(es),
		Att: 2 Summons(es),
		Att: 3 Summons(es),
		Att: 4 Summons(es),
		Att: 5 Summons(es),
		Att: 6 Summons(es),
		Att: 7 Summons(es),
		Att: 8 Summons(es),
		Att: 9 Summons(es),
		Att: 10 Summons(es),
		Att: 11 Summons(es),
		Att: 12 Summons(es),
		Att: 13 Summons(es),
		Att: 14 Summons(es),
		Att: 15 Summons(es),
		Att: 16 Summons(es),
		Att: 17 Summons(es),
		Att: 18 Summons(es)
3		3 NOTICE of Attorney Appearance by John F Walker on behalf of County of Morris (Walker, John) [Transferred from txed on 12/15/2017.] Related: [-]
4		4 NOTICE of Attorney Appearance by Reid William Martin on behalf of County of Morris (Martin, Reid) [Transferred from txed on 12/15/2017.] Related: [-]
Monday, November 06, 2017
5		5 ORDER OF RECUSAL. District Judge Rodney Gilstrap recused. Case reassigned to District Judge Robert W. Schroeder, III for all further proceedings. Signed by District Judge Rodney Gilstrap on 11/6/2017. (ch, ) [Transferred from txed on 12/15/2017.] Related: [-]
Thursday, November 16, 2017
		Defendant's Unopposed First Application for Extension of Time to Answer Complaint is granted pursuant to Local Rule CV-12 for McKesson Corporation to 1/4/2018. 30 Days Granted for Deadline Extension.( sm, ) [Transferred from txed on 12/15/2017.] Related: [-]
		Defendant's Unopposed Second Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for McKesson Corporation to 1/19/2018. 15 Days Granted for Deadline Extension.( sm, ) [Transferred from txed on 12/15/2017.] Related: [-]
6		6 Defendant's Unopposed First Application for Extension of Time to Answer Complaint re McKesson Corporation.( Scott, Robert) [Transferred from txed on 12/15/2017.] Related: [-]
7		7 Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re McKesson Corporation.( Scott, Robert) [Transferred from txed on 12/15/2017.] Related: [-]
Tuesday, November 21, 2017
		Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Cardinal Health, Inc. to 1/4/2018. 30 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/15/2017.] Related: [-]
		Defendant's Unopposed Second Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Cardinal Health, Inc. to 1/19/2018. 15 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/15/2017.] Related: [-]
8		8 NOTICE of Attorney Appearance by Amy M. Carter on behalf of County of Morris (Carter, Amy) [Transferred from txed on 12/15/2017.] Related: [-]
9		9 Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Cardinal Health, Inc..( Geyer, Christopher) [Transferred from txed on 12/15/2017.] Related: [-]
10		10 Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Cardinal Health, Inc..( Geyer, Christopher) [Transferred from txed on 12/15/2017.] Related: [-]
Wednesday, November 22, 2017
		Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for AmerisourceBergen Corporation to 1/5/2018. 30 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/15/2017.] Related: [-]
11		11 Defendant's Unopposed First Application for Extension of Time to Answer Complaint re AmerisourceBergen Corporation.( Smith, Melissa) [Transferred from txed on 12/15/2017.] Related: [-]
12		12 First MOTION for Extension of Time to File Answer by Abbott Laboratories Inc.(Ertas, Alper) [Transferred from txed on 12/15/2017.] Related: [-]
		Att: 1 Text of Proposed Order
Monday, November 27, 2017
		Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Knoll Pharmaceutical Company to 1/5/2018. 28 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/15/2017.] Related: [-]
		Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Insys Therapeutics, Inc. to 1/3/2018. 30 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/15/2017.] Related: [-]
13		13 Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Knoll Pharmaceutical Company.( Wilkes, John) [Transferred from txed on 12/15/2017.] Related: [-]
14		14 Defendant's Unopposed First Application for Extension of Time to Answer Complaint re INSYS Therapeutics, Inc.( Sarokhanian, Nicholas) [Transferred from txed on 12/15/2017.] Related: [-]
15		15 CORPORATE DISCLOSURE STATEMENT filed by Insys Therapeutics, Inc. (Sarokhanian, Nicholas) [Transferred from txed on 12/15/2017.] Related: [-]
16		16 Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re AmerisourceBergen Corporation.( Smith, Melissa) [Transferred from txed on 12/15/2017.] Related: [-]
17		17 First MOTION for Extension of Time to File Answer re12 First MOTION for Extension of Time to File Answer by Abbott Laboratories Inc.(Ertas, Alper) [Transferred from txed on 12/15/2017.] Related: [-]
		Att: 1 Text of Proposed Order
Tuesday, November 28, 2017
		Defendant's Unopposed Second Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for AmerisourceBergen Corporation to 1/20/2018. 15 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/15/2017.] Related: [-]
18		18 Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Purdue Pharma Inc.( Reed, Noelle) [Transferred from txed on 12/15/2017.] Related: [-]
19		19 Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Purdue Pharma L.P..( Reed, Noelle) [Transferred from txed on 12/15/2017.] Related: [-]
20		20 Defendant's Unopposed First Application for Extension of Time to Answer Complaint re The Purdue Frederick Company.( Reed, Noelle) [Transferred from txed on 12/15/2017.] Related: [-]
21		21 CORPORATE DISCLOSURE STATEMENT filed by Purdue Pharma Inc, Purdue Pharma L.P., The Purdue Frederick Company Related [+] [Transferred from txed on 12/15/2017.] Related: [-] ed, Noelle
22		22 Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Purdue Pharma Inc.( Reed, Noelle) [Transferred from txed on 12/15/2017.] Related: [-]
23		23 Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Purdue Pharma L.P..( Reed, Noelle) [Transferred from txed on 12/15/2017.] Related: [-]
24		24 Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re The Purdue Frederick Company.( Reed, Noelle) [Transferred from txed on 12/15/2017.] Related: [-]
Wednesday, November 29, 2017
		Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Purdue Pharma Inc to 1/3/2018. 30 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/15/2017.] Related: [-]
		Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Purdue Pharma L.P. to 1/3/2018. 30 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/15/2017.] Related: [-]
		Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for The Purdue Frederick Company to 1/3/2018. 30 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/15/2017.] Related: [-]
		Defendant's Unopposed Second Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Purdue Pharma Inc to 1/18/2018. 15 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/15/2017.] Related: [-]
		Defendant's Unopposed Second Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Purdue Pharma L.P. to 1/18/2018. 15 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/15/2017.] Related: [-]
		Defendant's Unopposed Second Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for The Purdue Frederick Company to 1/18/2018. 15 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/15/2017.] Related: [-]
Thursday, November 30, 2017
		Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Allergan Finance LLC to 1/3/2018. 30 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/15/2017.] Related: [-]
		Defendant's Unopposed Second Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Allergan Finance LLC to 1/18/2018. 15 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/15/2017.] Related: [-]
25		25 CORPORATE DISCLOSURE STATEMENT filed by AmerisourceBergen Corporation (Smith, Melissa) [Transferred from txed on 12/15/2017.] Related: [-]
26		26 Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Allergan Finance LLC.( Hill, Jack) [Transferred from txed on 12/15/2017.] Related: [-]
27		27 Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Allergan Finance LLC.( Hill, Jack) [Transferred from txed on 12/15/2017.] Related: [-]
Friday, December 01, 2017
		Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Endo Health Solutions Inc. to 1/5/2018. 30 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/15/2017.] Related: [-]
		Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Endo Pharmaceuticals Inc. to 1/3/2018. 30 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/15/2017.] Related: [-]
		Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Johnson & Johnson to 12/29/2017. 28 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/15/2017.] Related: [-]
		Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Janssen Pharmaceutica Inc to 12/29/2017. 25 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/15/2017.] Related: [-]
		Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Janssen Pharmaceuticals, Inc. to 12/29/2017. 25 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/15/2017.] Related: [-]
		Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Ortho-McNeil-Janssen Pharmaceuticals, Inc. to 12/29/2017. 25 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/15/2017.] Related: [-]
		Defendant's Unopposed Second Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Endo Health Solutions Inc. to 1/22/2018. 15 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/15/2017.] Related: [-]
		Defendant's Unopposed Second Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Endo Pharmaceuticals Inc. to 1/18/2018. 15 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/15/2017.] Related: [-]
		Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Actavis Pharma, Inc. to 1/3/2018. 30 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/15/2017.] Related: [-]
		Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Actavis LLC to 1/4/2018. 30 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/15/2017.] Related: [-]
		Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Watson Laboratories, Inc. to 1/3/2018. 30 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/15/2017.] Related: [-]
		Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Teva Pharmaceuticals USA, Inc. to 1/4/2018. 30 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/15/2017.] Related: [-]
		Defendant's Unopposed First Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Cephalon Inc. to 1/4/2018. 30 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/15/2017.] Related: [-]
		Defendant's Unopposed Second Application for Extension of Time to Answer Complaint is GRANTED pursuant to Local Rule CV-12 for Insys Therapeutics, Inc. to 1/18/2018. 15 Days Granted for Deadline Extension.( slo, ) [Transferred from txed on 12/15/2017.] Related: [-]
28		28 CORPORATE DISCLOSURE STATEMENT filed by Endo Health Solutions Inc., Endo Pharmaceuticals Inc. (Sibiski, Hannah) [Transferred from txed on 12/15/2017.] Related: [-]
29		29 Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Endo Health Solutions Inc..(Sibiski, Hannah) [Transferred from txed on 12/15/2017.] Related: [-]
30		30 Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Endo Pharmaceuticals Inc..(Sibiski, Hannah) [Transferred from txed on 12/15/2017.] Related: [-]
31		31 NOTICE of Attorney Appearance by Stephen Edward McConnico on behalf of Janssen Pharmaceutica Inc, Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc. (McConnico, Stephen) [Transferred from txed on 12/15/2017.] Related: [-]
32		32 Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Johnson & Johnson.( McConnico, Stephen) [Transferred from txed on 12/15/2017.] Related: [-]
33		33 Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Janssen Pharmaceutica Inc.( McConnico, Stephen) [Transferred from txed on 12/15/2017.] Related: [-]
34		34 Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Janssen Pharmaceuticals, Inc..( McConnico, Stephen) [Transferred from txed on 12/15/2017.] Related: [-]
35		35 Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Ortho-McNeil-Janssen Pharmaceuticals, Inc..( McConnico, Stephen) [Transferred from txed on 12/15/2017.] Related: [-]
36		36 CORPORATE DISCLOSURE STATEMENT filed by Janssen Pharmaceutica Inc, Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc. (McConnico, Stephen) [Transferred from txed on 12/15/2017.] Related: [-]
37		37 Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Endo Health Solutions Inc..(Sibiski, Hannah) [Transferred from txed on 12/15/2017.] Related: [-]
38		38 Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Endo Pharmaceuticals Inc..(Sibiski, Hannah) [Transferred from txed on 12/15/2017.] Related: [-]
39		39 Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Actavis Pharma, Inc..( Stanfield, Craig) [Transferred from txed on 12/15/2017.] Related: [-]
40		40 Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Actavis LLC.( Stanfield, Craig) [Transferred from txed on 12/15/2017.] Related: [-]
41		41 Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Watson Laboratories, Inc..( Stanfield, Craig) [Transferred from txed on 12/15/2017.] Related: [-]
42		42 Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Teva Pharmaceuticals USA, Inc..( Stanfield, Craig) [Transferred from txed on 12/15/2017.] Related: [-]
43		43 Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Cephalon Inc..( Stanfield, Craig) [Transferred from txed on 12/15/2017.] Related: [-]
44		44 CORPORATE DISCLOSURE STATEMENT filed by Cephalon Inc., Teva Pharmaceuticals USA, Inc. (Stanfield, Craig) [Transferred from txed on 12/15/2017.] Related: [-]
45		45 CORPORATE DISCLOSURE STATEMENT filed by Actavis LLC, Actavis Pharma, Inc., Watson Laboratories, Inc. identifying Corporate Parent Teva Pharmaceuticals Industries, Ltd. for Actavis LLC, Actavis Pharma, Inc., Watson Laboratories, Inc.. (Stanfield, Craig) [Transferred from txed on 12/15/2017.] Related: [-]
46		46 Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re INSYS Therapeutics, Inc.(Sarokhanian, Nicholas) [Transferred from txed on 12/15/2017.] Related: [-]
Thursday, December 07, 2017
47		47 NOTICE of Attorney Appearance - Pro Hac Vice by James K. O'Connor on behalf of Abbott Laboratories Inc. Filing fee $ 100, receipt number 0540-6579523. (O'Connor, James) [Transferred from txed on 12/15/2017.] Related: [-]
48		48 NOTICE of Attorney Appearance - Pro Hac Vice by John A McCauley on behalf of Abbott Laboratories Inc. Filing fee $ 100, receipt number 0540-6579652. (McCauley, John) [Transferred from txed on 12/15/2017.] Related: [-]
Thursday, December 14, 2017
49		49 CONDITIONAL TRANSFER ORDER (CTO-1) (ch, ) [Transferred from txed on 12/15/2017.] Related: [-]
Friday, December 15, 2017
		Interdistrict transfer to the Northern District of Ohio. (ch, ) [Transferred from txed on 12/15/2017.] Related: [-]
50		50 CASE TRANSFERRED IN from District of Texas Eastern. Case number 2:17-cv-00725. Electronic file and copy of transfer order and docket sheet received. Related: [-]

Continue to Create Account